drugset / Trial / NCT05891262
A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effect of BMS-986196 when coadministered with combined hormonal oral contraceptives (ethinyl estradiol \[EE\] and norethindrone \[NET\]) in healthy female participants.
Timeline
- Start
- 2023-06-06
- Primary completion
- 2023-08-25
- Completion
- 2023-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986196 | Unknown | — | — |
| Background | Loestrin | Unknown | — | — |
Indications
No indication recorded.